氧化应激,高密度脂蛋白和上腺炎:一个前性研究
Elisa Molinelli1, Camilla Morresi2, Maria Luisa Dragonetti1
1Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy.
Antioxidants (Basel, Switzerland)
|August 28, 2025
概括
高密度脂蛋白 (HDL) 抗氧化功能受损. 这些HDL变化与HS的严重程度相关,这表明它在疾病的发病过程中起作用.
科学领域:
- 皮肤病学
- 免疫学
- 心血管研究
背景情况:
- 补腺炎 (HS) 是一种慢性炎症性皮肤疾病,与并发症和血管风险有关.
- 氧化应激,炎症和高密度脂蛋白 (HDL) 功能的改变与炎症性皮肤疾病有关.
- 这些因素与HS病变的具体相互作用尚不完全理解.
研究的目的:
- 研究HS,氧化应激,炎症和HDL功能之间的关系.
- 分析炎症标志物 (SAA,MCP-1) 和与HDL相关的抗氧化特性 (PON1活性,HDL氧化还原状态).
- 将这些标记与HS的严重程度相关联.
主要方法:
- 在44名HS患者和16名健康对照人群中测量了SAA和MCP-1的血清水平.
- 评估了一种与HDL相关的抗氧化酶 - - 氧酶-1 (PON1) 的活性.
- 使用无细胞方法评估了HDL氧化还原特性.
主要成果:
- 与对照组相比,HS患者的MCP- 1和SAA血清水平显著升高.
- 在HS患者中,PON1活性显著降低,表明HDL抗氧化能力受损.
- 这些HDL功能障碍与HS严重程度相关,独立于血HDL水平.
结论:
- 炎症和氧化应激可能导致HS患者的HDL功能障碍.
- 功能障碍的HDL可能在HS的发病和相关并发症中起作用.
- 针对HDL功能障碍为HS提供了潜在的治疗途径.
相关概念视频
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Atherosclerosis I: Introduction
76
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
76
Psychoneuroimmunology: Cardiovascular Disease
77
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
77
Lipid-derived Compounds in the Human Body
5.2K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.2K
Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33


